452 related articles for article (PubMed ID: 18242217)
1. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss.
Nozaki K; Ogawa M; Williams JA; Lafleur BJ; Ng V; Drapkin RI; Mills JC; Konieczny SF; Nomura S; Goldenring JR
Gastroenterology; 2008 Feb; 134(2):511-22. PubMed ID: 18242217
[TBL] [Abstract][Full Text] [Related]
2. Altered gastric chief cell lineage differentiation in histamine-deficient mice.
Nozaki K; Weis V; Wang TC; Falus A; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1211-20. PubMed ID: 19359424
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia.
Nam KT; Lee HJ; Mok H; Romero-Gallo J; Crowe JE; Peek RM; Goldenring JR
Gastroenterology; 2009 Apr; 136(4):1288-96. PubMed ID: 19230855
[TBL] [Abstract][Full Text] [Related]
4. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice.
Nomura S; Yamaguchi H; Ogawa M; Wang TC; Lee JR; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G362-75. PubMed ID: 15647607
[TBL] [Abstract][Full Text] [Related]
5. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy.
Ogawa M; Nomura S; Varro A; Wang TC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G793-804. PubMed ID: 16306133
[TBL] [Abstract][Full Text] [Related]
6. Maturity and age influence chief cell ability to transdifferentiate into metaplasia.
Weis VG; Petersen CP; Weis JA; Meyer AR; Choi E; Mills JC; Goldenring JR
Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G67-G76. PubMed ID: 27881402
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice.
Nam KT; Varro A; Coffey RJ; Goldenring JR
Gastroenterology; 2007 May; 132(5):1804-19. PubMed ID: 17484876
[TBL] [Abstract][Full Text] [Related]
8. Mature chief cells are cryptic progenitors for metaplasia in the stomach.
Nam KT; Lee HJ; Sousa JF; Weis VG; O'Neal RL; Finke PE; Romero-Gallo J; Shi G; Mills JC; Peek RM; Konieczny SF; Goldenring JR
Gastroenterology; 2010 Dec; 139(6):2028-2037.e9. PubMed ID: 20854822
[TBL] [Abstract][Full Text] [Related]
9. Macrophages promote progression of spasmolytic polypeptide-expressing metaplasia after acute loss of parietal cells.
Petersen CP; Weis VG; Nam KT; Sousa JF; Fingleton B; Goldenring JR
Gastroenterology; 2014 Jun; 146(7):1727-38.e8. PubMed ID: 24534633
[TBL] [Abstract][Full Text] [Related]
10. Alterations in gastric mucosal lineages before or after acute oxyntic atrophy in gastrin receptor and H2 histamine receptor-deficient mice.
Aikou S; Fukushima Y; Ogawa M; Nozaki K; Saito T; Matsui T; Goldenring JR; Kaminishi M; Nomura S
Dig Dis Sci; 2009 Aug; 54(8):1625-35. PubMed ID: 19507031
[TBL] [Abstract][Full Text] [Related]
11. Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation.
Shimizu T; Sohn Y; Choi E; Petersen CP; Prasad N; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2020; 9(1):61-78. PubMed ID: 31473306
[TBL] [Abstract][Full Text] [Related]
12. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H. felis-infected mice.
Nomura S; Baxter T; Yamaguchi H; Leys C; Vartapetian AB; Fox JG; Lee JR; Wang TC; Goldenring JR
Gastroenterology; 2004 Aug; 127(2):582-94. PubMed ID: 15300590
[TBL] [Abstract][Full Text] [Related]
13. Spasmolytic polypeptide-expressing metaplasia (SPEM) in the gastric oxyntic mucosa does not arise from Lgr5-expressing cells.
Nam KT; O'Neal RL; Coffey RJ; Finke PE; Barker N; Goldenring JR
Gut; 2012 Dec; 61(12):1678-85. PubMed ID: 22198711
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of SPEM and its standing in the preneoplastic process.
Weis VG; Goldenring JR
Gastric Cancer; 2009; 12(4):189-97. PubMed ID: 20047123
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in mouse spasmolytic polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression.
Weis VG; Sousa JF; LaFleur BJ; Nam KT; Weis JA; Finke PE; Ameen NA; Fox JG; Goldenring JR
Gut; 2013 Sep; 62(9):1270-9. PubMed ID: 22773549
[TBL] [Abstract][Full Text] [Related]
16. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats.
Yamaguchi H; Goldenring JR; Kaminishi M; Lee JR
Lab Invest; 2002 Aug; 82(8):1045-52. PubMed ID: 12177243
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia.
Goldenring JR; Nomura S
Am J Physiol Gastrointest Liver Physiol; 2006 Dec; 291(6):G999-1004. PubMed ID: 17090722
[TBL] [Abstract][Full Text] [Related]
18. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.
Choi E; Hendley AM; Bailey JM; Leach SD; Goldenring JR
Gastroenterology; 2016 Apr; 150(4):918-30.e13. PubMed ID: 26677984
[TBL] [Abstract][Full Text] [Related]
19. Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells.
Radyk MD; Burclaff J; Willet SG; Mills JC
Gastroenterology; 2018 Mar; 154(4):839-843.e2. PubMed ID: 29248442
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.
Lennerz JK; Kim SH; Oates EL; Huh WJ; Doherty JM; Tian X; Bredemeyer AJ; Goldenring JR; Lauwers GY; Shin YK; Mills JC
Am J Pathol; 2010 Sep; 177(3):1514-33. PubMed ID: 20709804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]